533 related articles for article (PubMed ID: 16029352)
1. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.
Brown M; Noursadeghi M; Boyle J; Davidson RN
Br J Dermatol; 2005 Jul; 153(1):203-5. PubMed ID: 16029352
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
[TBL] [Abstract][Full Text] [Related]
3. [Leishmania braziliensis: report of a pediatric imported case with response to liposomal amphotericin B].
Campos-Muñoz L; Quesada-Cortés A; Martín-Díaz MA; Rubio-Flores C; de Lucas-Laguna R
Actas Dermosifiliogr; 2007; 98(1):42-4. PubMed ID: 17374332
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.
del Rosal T; Artigao FB; Miguel MJ; de Lucas R; del Castillo F
J Trop Pediatr; 2010 Apr; 56(2):122-4. PubMed ID: 19656844
[TBL] [Abstract][Full Text] [Related]
5. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
Solomon M; Pavlotzky F; Barzilai A; Schwartz E
J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
[TBL] [Abstract][Full Text] [Related]
6. [Cutaneous leishmaniasis treated with ambisome (liposomal amphotericin B)].
Ben-Shimol S; Sagi O; Schwartz E; Greenberg D
Harefuah; 2012 Aug; 151(8):458-60, 498. PubMed ID: 23350289
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients.
Amato VS; Rabello A; Rotondo-Silva A; Kono A; Maldonado TP; Alves IC; Floeter-Winter LM; Neto VA; Shikanai-Yasuda MA
Acta Trop; 2004 Oct; 92(2):127-32. PubMed ID: 15350864
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.
Solomon M; Pavlotsky F; Leshem E; Ephros M; Trau H; Schwartz E
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):973-7. PubMed ID: 21129042
[TBL] [Abstract][Full Text] [Related]
9. Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.
Kosaka A; Sakamoto N; Hikone M; Imai K; Ota M; Washino T; Maeda T; Iwabuchi S
Intern Med; 2020; 59(9):1227-1230. PubMed ID: 32378656
[TBL] [Abstract][Full Text] [Related]
10. A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis.
Motta JO; Sampaio RN
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):331-5. PubMed ID: 21492255
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of cutaneous leishmaniasis with liposomal amphotericin B].
del Rosal Rabes T; Baquero-Artigao F; Gómez Fernández C; García Miguel MJ; de Lucas Laguna R
An Pediatr (Barc); 2010 Aug; 73(2):101-2. PubMed ID: 20615769
[No Abstract] [Full Text] [Related]
12. Old world Leishmania infantum cutaneous leishmaniasis unresponsive to liposomal amphotericin B treated with topical imiquimod.
Hervás JA; Martín-Santiago A; Hervás D; Rojo E; Mena A; Rocamora V; Dueñas J
Pediatr Infect Dis J; 2012 Jan; 31(1):97-100. PubMed ID: 21829140
[TBL] [Abstract][Full Text] [Related]
13. [First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France].
Minodier P; Robert S; Noël G; Blanc P; Retornaz K; Garnier JM
Arch Pediatr; 2005 Jul; 12(7):1102-8. PubMed ID: 15964525
[TBL] [Abstract][Full Text] [Related]
14. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
[TBL] [Abstract][Full Text] [Related]
15. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
16. Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.
Paradisi A; Capizzi R; Zampetti A; Proietti I; De Simone C; Feliciani C; Amerio PL
J Infect; 2005 Dec; 51(5):e261-4. PubMed ID: 15936088
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).
Musa AM; Khalil EA; Mahgoub FA; Hamad S; Elkadaru AM; El Hassan AM
Ann Trop Med Parasitol; 2005 Sep; 99(6):563-9. PubMed ID: 16156969
[TBL] [Abstract][Full Text] [Related]
19. [A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B].
Taquin H; Chiaverini C; Marty P; Lacour JP
Ann Dermatol Venereol; 2016 Oct; 143(10):622-624. PubMed ID: 27292718
[TBL] [Abstract][Full Text] [Related]
20. High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis.
Sousa AQ; Frutuoso MS; Moraes EA; Pearson RD; Pompeu MM
Clin Infect Dis; 2011 Oct; 53(7):693-5. PubMed ID: 21890773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]